Security key
03879J100
Arbutus Biopharma Corp - Common Shares, without par value (ABUS)
CUSIP: 03879J100
Q1 2017 13F Holders as of 31 Mar 2017
- Security type / class
- Equity / Common Shares, without par value
- Total 13F shares
- 36,322,621
- Total 13F value
- $118,047,315
- Share change
- +113,993
- Put/Call ratio
- 2400%
- SEC-reported price per share
- $3.25
- Number of holders
- 50
- Value change
- +$819,274
- Number of buys
- 19
- Number of sells
- 31
- Shares outstanding
- 197,420,670
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q1 2017
Institutions
50
Top holders
10
ABUS full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q2 2017
Previous quarter: Q4 2016
Arbutus Biopharma Corp SEC filings
Arbutus Biopharma Corp company facts
Broader feeds
Reporting periods
Holder history for CUSIP 03879J100
Recent filing periods:
Ownership snapshot
Top reported holders of ABUS - Arbutus Biopharma Corp - Common Shares, without par value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
QVT Financial LP
Disclosed value leader
QVT Financial LP
Comparable rows
15/15
Latest evidence
31 Dec 2016
13F
Lead comparable stake: 8.1%
Showing 1-6 of 15 holder rows.
Quick read
QVT Financial LP leads the comparable SEC ownership view at 8.1%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens QVT Financial LP's linked filing trail.
Comparable ownership
Top 5
QVT Financial LP
8.1%
LADENBURG THALMANN FINANCIAL SERV...
2.7%
PRIMECAP MANAGEMENT CO/CA/
2%
ARMISTICE CAPITAL, LLC
0.98%
D. E. Shaw & Co., Inc.
0.88%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| QVT Financial LP |
13F
Company
|
8.1%
|
$39,233,000
16,013,540 shares
|
— | 31 Dec 2016 |
| LADENBURG THALMANN FINANCIAL SERVICES INC. |
13F
Company
|
2.7%
|
$12,972,000
5,294,945 shares
|
— | 31 Dec 2016 |
| PRIMECAP MANAGEMENT CO/CA/ |
13F
Company
|
2%
|
$9,641,000
3,935,000 shares
|
— | 31 Dec 2016 |
| ARMISTICE CAPITAL, LLC |
13F
Company
|
0.98%
|
$4,753,000
1,940,000 shares
|
— | 31 Dec 2016 |
| D. E. Shaw & Co., Inc. |
13F
Company
|
0.88%
|
$4,250,000
1,734,603 shares
|
— | 31 Dec 2016 |
| Alpha Wave Global, LP |
13F
Company
|
0.84%
|
$4,055,000
1,655,162 shares
|
— | 31 Dec 2016 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q1 2017
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
50
Shares
36,322,621
Rows available
50
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q1 2017 vs Q4 2016 Across Filers
Q4 2016 holders
52
Q1 2017 holders
50
Holder diff
-2
| Investor | Q4 2016 Shares | Q1 2017 Shares | Share Diff | Share Chg % | Q4 2016 value | Q1 2017 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend